Citadel Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-30,684
| Closed | -$26K | – | 10679 |
|
|
2019
Q4 | $26K | Buy |
+30,684
| New | +$23.6K | ﹤0.01% | 8904 |
|
|
2019
Q3 | – | Sell |
-134,965
| Closed | -$70K | – | 10255 |
|
|
2019
Q2 | $70K | Sell |
134,965
-87,250
| -39% | -$43.6K | ﹤0.01% | 8640 |
|
|
2019
Q1 | $100K | Buy |
222,215
+208,000
| +1,463% | +$97.1K | ﹤0.01% | 8561 |
|
|
2018
Q4 | $7K | Sell |
14,215
-46,593
| -77% | -$23.1K | ﹤0.01% | 8973 |
|
|
2018
Q3 | $34K | Buy |
60,808
+50,544
| +492% | +$27.1K | ﹤0.01% | 8902 |
|
|
2018
Q2 | $5K | Buy |
+10,264
| New | +$4.78K | ﹤0.01% | 8739 |
|
|
2018
Q1 | – | Sell |
-76,245
| Closed | -$29K | – | 9303 |
|
|
2017
Q4 | $29K | Sell |
76,245
-11,166
| -13% | -$4.24K | ﹤0.01% | 7775 |
|
|
2017
Q3 | $31K | Buy |
87,411
+35,670
| +69% | +$13.2K | ﹤0.01% | 7286 |
|
|
2017
Q2 | $20K | Buy |
51,741
+6,941
| +15% | +$2.83K | ﹤0.01% | 7300 |
|
|
2017
Q1 | $20K | Sell |
44,800
-10,927
| -20% | -$4.8K | ﹤0.01% | 7254 |
|
|
2016
Q4 | $21K | Sell |
55,727
-19,919
| -26% | -$6.74K | ﹤0.01% | 7084 |
|
|
2016
Q3 | $20K | Buy |
75,646
+14,913
| +25% | +$3.78K | ﹤0.01% | 7062 |
|
|
2016
Q2 | $15K | Buy |
+60,733
| New | +$10.4K | ﹤0.01% | 6694 |
|
|
2016
Q1 | – | Sell |
-271,701
| Closed | -$31K | – | 9367 |
|
|
2015
Q4 | $31K | Buy |
271,701
+103,217
| +61% | +$14.6K | ﹤0.01% | 7665 |
|
|
2015
Q3 | $32K | Buy |
168,484
+98,879
| +142% | +$33.6K | ﹤0.01% | 7892 |
|
|
2015
Q2 | $49K | Buy |
69,605
+20,451
| +42% | +$14.1K | ﹤0.01% | 7676 |
|
|
2015
Q1 | $33K | Buy |
49,154
+31,214
| +174% | +$21.8K | ﹤0.01% | 7654 |
|
|
2014
Q4 | $14K | Sell |
17,940
-12,079
| -40% | -$8.25K | ﹤0.01% | 8026 |
|
|
2014
Q3 | $14K | Sell |
30,019
-11,669
| -28% | -$5.66K | ﹤0.01% | 7667 |
|
|
2014
Q2 | $21K | Sell |
41,688
-142,961
| -77% | -$69.1K | ﹤0.01% | 7272 |
|
|
2014
Q1 | $59K | Buy |
+184,649
| New | +$68.6K | ﹤0.01% | 6644 |
|
Citadel Advisors's GCVRZ Position: Q1 2020 in Review
Citadel Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 30,684 shares — an estimated $26K sold.
Citadel Advisors first reported a position in GCVRZ in Q1 2014 and held it in 21 quarters. The position peaked at $100K in Q1 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Citadel Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 30,684 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $26K.
- Citadel Advisors first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 21 quarters.
- Citadel Advisors's Sanofi Contingent Value Rights position peaked at $100K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.